subscribeSubscribe
PassPort Tech Announces Positive Results of Zolmitriptan for the Treatment of AM

PassPort Tech Announces Positive Results of Zolmitriptan for the Treatment of AM
PR NEWSWIRE
29 Mar 2024
Share Share
PassPort Initiated Ph I Trial of Zolmitriptan Transdermal Microporation System

PassPort Initiated Ph I Trial of Zolmitriptan Transdermal Microporation System
PR NEWSWIRE
23 Feb 2024
Share Share
Migraine patch developer Zosano Pharma suspends program

Migraine patch developer Zosano Pharma suspends program
R. Leuty BIZJOURNALS
04 May 2022
Share Share
FDA Rejects Zosano`s Application For Zolmitriptan Microneedle System Again

FDA Rejects Zosano`s Application For Zolmitriptan Microneedle System Again
BENZINGA
22 Feb 2022
Share Share
Padagis Announces The First-to-Market Launch Of An AB Rated Generic Zomig

Padagis Announces The First-to-Market Launch Of An AB Rated Generic Zomig
PRNEWSWIRE
16 Nov 2021
Share Share
Padagis Launches AB Rated Generic Version Of Zomig Nasal Spray

Padagis Launches AB Rated Generic Version Of Zomig Nasal Spray
PRNEWSWIRE
16 Nov 2021
Share Share
Zosano evaluates C213 in Phase II/III cluster headache trial

Zosano evaluates C213 in Phase II/III cluster headache trial
CLINICALTRIALSARENA
25 Oct 2019
Share Share
Zosano Pharma Initiates Phase 2/3 Clinical Study in Second Late Stage Program

Zosano Pharma Initiates Phase 2/3 Clinical Study in Second Late Stage Program
BIOSPACE
24 Oct 2019
Share Share
Zosano launches Phase 2/3 study of zolmitriptan for cluster headache

Zosano launches Phase 2/3 study of zolmitriptan for cluster headache
Douglas W. House SEEKINGALPHA
24 Oct 2019
Share Share
Orchid Hlthcare’S Generic Zolmitriptan Receives Approval In US

Orchid Hlthcare’S Generic Zolmitriptan Receives Approval In US
FDA
23 Oct 2019
Share Share